These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 18730914)

  • 1. Current treatment of myelodysplasia.
    Banta JV
    Calif Med; 1973 Mar; 118(3):32. PubMed ID: 18730914
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibiting the NLRP3 Inflammasome With Methylene Blue as Treatment Adjunct in Myelodysplasia.
    Kast RE
    Front Oncol; 2018; 8():280. PubMed ID: 30101125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia.
    Witherspoon RP; Deeg HJ
    Haematologica; 1999 Dec; 84(12):1085-7. PubMed ID: 10586209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro.
    Bouscary D; Chen YL; Guesnu M; Picard F; Viguier F; Lacombe C; Dreyfus F; Fontenay-Roupie M
    Exp Hematol; 2000 Jul; 28(7):784-91. PubMed ID: 10907640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis.
    Gertz MA; Lacy MQ; Lust JA; Greipp PR; Witzig TE; Kyle RA
    Haematologica; 2008 Sep; 93(9):1402-6. PubMed ID: 18641023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia.
    Sasai Y; Horiike S; Misawa S; Kaneko H; Kobayashi M; Fujii H; Kashima K; Taniwaki M
    Leuk Res; 1999 Nov; 23(11):975-81. PubMed ID: 10576500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral circulation in patients with myelodysplasia.
    Sun EC; Yen YM; Ip T; Otsuka NY
    J Pediatr Orthop; 2003; 23(6):714-7. PubMed ID: 14581772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute leukemia and myelodysplasia after adjuvant chemotherapy for breast cancer: durable remissions after hematopoietic stem cell transplantation.
    Pullarkat V; Slovak ML; Dagis A; Bedell V; Somlo G; Nakamura R; Stein AS; O'Donnell MR; Nademanee A; Teotico AL; Bhatia S; Forman SJ
    Ann Oncol; 2009 Dec; 20(12):2000-6. PubMed ID: 19564171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune manifestations in human myelodysplasia: a positive correlation with interferon regulatory factor-1 (IRF-1) expression.
    Giannouli S; Tzoanopoulos D; Ritis K; Kartalis G; Moutsopoulos HM; Voulgarelis M
    Ann Rheum Dis; 2004 May; 63(5):578-82. PubMed ID: 15082491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelodysplasia in Ugandan patients with HIV/AIDS: an autopsy study.
    Nabadda S; Odida M; Wabinga H
    East Afr Med J; 2011 Jan; 88(1):24-7. PubMed ID: 24968599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplasia Following Treatment of Chronic Lymphocytic Leukaemia with Fludarabine.
    Hennessy BJ; Ryley S; Kasprzyk A; Reid CD
    Hematology; 1999; 4(6):495-7. PubMed ID: 27420744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary tract infections in children with myelodysplasia in whom clean intermittent catheterization was administered.
    Yıldız ZA; Candan C; Arga M; Turhan P; İşgüven P; Ergüven M
    Turk Pediatri Ars; 2014 Mar; 49(1):36-41. PubMed ID: 26078630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent myelodysplasia and lymphoproliferation: a disorder of the true pluripotential stem cell?
    Baumann MA; Libnoch JA; Hansen RM; Heckman MG; Hanson GA
    Q J Med; 1985 Jun; 55(218):199-211. PubMed ID: 4023169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary myelodysplasia: management and outcome at 3 years in 45 patients age 65 and older.
    Tilly-Gentric A; Malo JP; Marion V
    J Am Geriatr Soc; 2001 Oct; 49(10):1358-60. PubMed ID: 11890496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the pathomorphology of myelodysplasia.
    Wang D; Bai X; Sun D; Han K; Li J
    Pediatr Neurosurg; 2008; 44(6):458-64. PubMed ID: 19018154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelodysplasia and myeloproliferative disorders.
    Anderson JE; Appelbaum FR
    Curr Opin Hematol; 1997 Jul; 4(4):261-7. PubMed ID: 9260054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Be careful of the masquerades: differentiating secondary myelodysplasia from myelodysplastic syndromes in clinical practice.
    Shallis RM; Xu ML; Podoltsev NA; Curtis SA; Considine BT; Khanna SR; Siddon AJ; Zeidan AM
    Ann Hematol; 2018 Dec; 97(12):2333-2343. PubMed ID: 30109425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myelodysplasia, vasculitis and anti-neutrophil cytoplasm antibodies.
    Savige JA; Chang L; Smith CL; Duggan JC
    Leuk Lymphoma; 1993 Jan; 9(1-2):49-54. PubMed ID: 8477201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood smears of myelodysplasia patients: scanning electron microscope findings.
    Terzakis JA; Taskin M
    Ultrastruct Pathol; 2008; 32(4):127-38. PubMed ID: 18696398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinico-electroneuromyographic characteristics of myelodysplasia in children].
    Shakhovskiĭ VA; Skvortsov IA; Kharina GV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(10):1493-6. PubMed ID: 3321790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.